Arthritis drug repurposed to fight stem cell transplant complication
Disease control
Recruiting now
This phase 3 trial tests whether iguratimod, a drug already used for rheumatoid arthritis, can safely and effectively treat chronic graft-versus-host disease (cGVHD) in people who have had a stem cell transplant. The study will enroll 20 adults who have persistent cGVHD despite p…
Phase: PHASE3 • Sponsor: Xuzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC